Marcio Souza - 25 Aug 2022 Form 4 Insider Report for Aeglea BioTherapeutics, Inc. (SYRE)

Role
Director
Signature
/s/ James Kastenmayer, by power of attorney
Issuer symbol
SYRE
Transactions as of
25 Aug 2022
Net transactions value
+$50,472
Form type
4
Filing time
25 Aug 2022, 19:37:05 UTC
Previous filing
24 Jun 2022
Next filing
21 Nov 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGLE Common Stock Purchase $50,472 +90,000 $0.5608 90,000 25 Aug 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.